CeriBell Past Earnings Performance
Past criteria checks 0/6
CeriBell's earnings have been declining at an average annual rate of -15.1%, while the Medical Equipment industry saw earnings growing at 13.2% annually. Revenues have been growing at an average rate of 48.8% per year.
Key information
-15.1%
Earnings growth rate
-9.5%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 48.8% |
| Return on equity | -316.3% |
| Net Margin | -60.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How CeriBell makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 60 | -36 | 74 | 12 |
| 30 Jun 24 | 54 | -33 | 68 | 11 |
| 31 Mar 24 | 50 | -31 | 63 | 10 |
| 31 Dec 23 | 45 | -29 | 59 | 9 |
| 31 Dec 22 | 26 | -37 | 50 | 7 |
Quality Earnings: CBLL is currently unprofitable.
Growing Profit Margin: CBLL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if CBLL's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare CBLL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CBLL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.6%).
Return on Equity
High ROE: CBLL has a negative Return on Equity (-316.3%), as it is currently unprofitable.